CHICAGO-Today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene’s ability to improve vision in people with certain incurable r…
Author: OphthalmologyWeb
Blood Pressure, Glaucoma Links In Migraine Patients; Eye Care Goes Digital And Mobile
CHICAGO-Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today’s Scientific Program, to be presented at the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of O…
Genetic Medicine And AMD Treatment; Genetic Screening And Glaucoma
CHICAGO – Genetic medicine is the focus of two presentations at today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session Octo…
A Dry AMD Treatment? Some Long-Term Diabetics Escape PDR
CHICAGO-At the American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting today, researchers report progress on two top eye disease challenges: treating advanced “dry” age-related macular degeneration, a…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY(TM)
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09% as a once-daily prescriptio…
Gene Therapy A Future Possibility In Glaucoma, Clinician Says
With 14 regions of the genome associated with primary open-angle glaucoma known and four genes identified, possible applications for genetics in glaucoma could include an additional therapeutic option, a clinician said here.
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Eye Exercises Might Boost Fine Depth Perception
A new study says a push-pull training method is a good way to correct a condition called sensory eye dominance, in which an imbalance between the vision strength of the eyes impairs fine depth perception.
MMC Effective For Ocular Surface Neoplasia, With Short- and Long-Term Complications
Topical mitomycin C chemotherapy yielded qualified success in managing ocular surface neoplasia, a study found.
"Poppers" May Cause Serious Eye Damage: Study
Getting high by inhaling the vapors of alkyl nitrite capsules, commonly known as “poppers,” can seriously damage the light-sensing cells lining the retina of the eye, French doctors reported on Wednesday.
Sequenom Announces Formation Of Ophthalmology Clinical Advisory Board
Sequenom, Inc. (Nasdaq: SQNM) today announced the formation of a new clinical advisory board focusing on retinal diseases and conditions. The initial three distinguished thought-leaders will provide guidance to Sequenom and Sequenom Center for Molecula…
Monthly Anti-VEGF Dosing Associated With Lowest Risk Of Macular Hemorrhage
Patients with neovascular age-related macular degeneration being treated with monthly dosing of intravitreal anti-VEGF therapy have the lowest rate of macular hemorrhage compared with patients treated with sham or alternative therapy and have lower rat…
California: Many Americans In The Dark When Protecting Their Eyes From The Sun
When it comes to working and playing in the great outdoors, many Americans know they should keep their skin protected from the sun; however, a new survey from Anthem Blue Cross’ parent company and Transitions Optical, Inc. indicates that the majority o…
10 Years And Counting: MedInformatix’ Practice Management And Electronic Medical Records Solution Provides Strong Support For Growing Midwest Eye Care
Since its initial installation of MedInformatix’ Practice Management (PM) and Electronic Medical Records (EMR) solution in 2000, Midwest Eye Care, P.C., Nebraska’s and Western Iowa’s leading eye care specialty practice, has grown from a seven- to 18-ph…
Beaver-Visitec International To Focus On Ophthalmic And Microsurgery Products And Services
Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for oph…
California: Many Americans In The Dark When Protecting Their Eyes From The Sun
When it comes to working and playing in the great outdoors, many Americans know they should keep their skin protected from the sun; however, a new survey from Anthem Blue Cross’ parent company and Transitions Optical, Inc. indicates that the majority o…
Beaver-Visitec International To Focus On Ophthalmic And Microsurgery Products And Services
Beaver-Visitec International (Beaver-Visitec), a new company formed from the purchase of the ophthalmic systems businesses from BD (Becton, Dickinson and Company) and Medtronic, announced today that it will focus solely on products and services for oph…